Kaufmann H - Search Results

1

New insights into the pathophysiology of multiple myeloma.

Seidl S, Kaufmann H, Drach J. Seidl S, et al. Among authors: kaufmann h. Lancet Oncol. 2003 Sep;4(9):557-64. doi: 10.1016/s1470-2045(03)01195-1. Lancet Oncol. 2003. PMID: 12965277 Review.

2

Both chromosome 13 abnormalities by metaphase cytogenetics and deletion of 13q by interphase FISH only are prognostically relevant in multiple myeloma.

Kaufmann H, Krömer E, Nösslinger T, Weltermann A, Ackermann J, Reisner R, Bernhart M, Drach J. Kaufmann H, et al. Eur J Haematol. 2003 Sep;71(3):179-83. doi: 10.1034/j.1600-0609.2003.00111.x. Eur J Haematol. 2003. PMID: 12930318

3

Low p27Kip1 expression is an independent adverse prognostic factor in patients with multiple myeloma.

Filipits M, Pohl G, Stranzl T, Kaufmann H, Ackermann J, Gisslinger H, Greinix H, Chott A, Drach J. Filipits M, et al. Among authors: kaufmann h. Clin Cancer Res. 2003 Feb;9(2):820-6. Clin Cancer Res. 2003. PMID: 12576455

4

Predictive role of interphase cytogenetics for survival of patients with multiple myeloma.

Königsberg R, Zojer N, Ackermann J, Krömer E, Kittler H, Fritz E, Kaufmann H, Nösslinger T, Riedl L, Gisslinger H, Jäger U, Simonitsch I, Heinz R, Ludwig H, Huber H, Drach J. Königsberg R, et al. Among authors: kaufmann h. J Clin Oncol. 2000 Feb;18(4):804-12. doi: 10.1200/JCO.2000.18.4.804. J Clin Oncol. 2000. PMID: 10673522

5

The biology of multiple myeloma.

Drach J, Kaufmann H, Urbauer E, Schreiber S, Ackermann J, Huber H. Drach J, et al. Among authors: kaufmann h. J Cancer Res Clin Oncol. 2000 Aug;126(8):441-7. J Cancer Res Clin Oncol. 2000. PMID: 10961386 Review.

6

Multiple myeloma with deletion of chromosome 13q is characterized by increased bone marrow neovascularization.

Schreiber S, Ackermann J, Obermair A, Kaufmann H, Urbauer E, Aletaha K, Gisslinger H, Chott A, Huber H, Drach J. Schreiber S, et al. Among authors: kaufmann h. Br J Haematol. 2000 Sep;110(3):605-9. doi: 10.1046/j.1365-2141.2000.02248.x. Br J Haematol. 2000. PMID: 10997971 Free article.

7

Advances in the biology and therapeutic management of multiple myeloma.

Kaufmann H, Urbauer E, Ackermann J, Huber H, Drach J. Kaufmann H, et al. Ann Hematol. 2001 Aug;80(8):445-51. doi: 10.1007/s002770100348. Ann Hematol. 2001. PMID: 11563588 Review.

8

New developments and treatment in multiple myeloma: new insights on molecular biology.

Drach J, Kaufmann H. Drach J, et al. Among authors: kaufmann h. Ann Oncol. 2002;13 Suppl 4:43-7. doi: 10.1093/annonc/mdf637. Ann Oncol. 2002. PMID: 12401665 Free article. Review. No abstract available.

9

Beneficial effect of high-dose chemotherapy in multiple myeloma patients with unfavorable prognostic features.

Kaufmann H, Ackermann J, Greinix H, Nösslinger T, Gisslinger H, Keck A, Ludwig H, Worel N, Kalhs P, Zielinski C, Drach J. Kaufmann H, et al. Ann Oncol. 2003 Nov;14(11):1667-72. doi: 10.1093/annonc/mdg454. Ann Oncol. 2003. PMID: 14581276 Free article. Clinical Trial.

10

Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma.

Kaufmann H, Ackermann J, Baldia C, Nösslinger T, Wieser R, Seidl S, Sagaster V, Gisslinger H, Jäger U, Pfeilstöcker M, Zielinski C, Drach J. Kaufmann H, et al. Leukemia. 2004 Nov;18(11):1879-82. doi: 10.1038/sj.leu.2403518. Leukemia. 2004. PMID: 15385925

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

796 results

Search Page